Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers

Speaking of SurgOnc - A podcast by Annals of Surgical Oncology and Society of Surgical Oncology - Tuesdays

Rick Greene, MD, discusses with Meghan R. Flanagan, MD, MPH, the results of a retrospective population-based study about genetic testing among patients with breast, ovarian, pancreatic and prostate cancers. Dr. Flanagan is author of, “Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.” Dr. Flanagan is Assistant Professor of Surgery at the University of Washington School of Medicine, Seattle, WA. http://doi.org/10.1245/S10434-022-12755-Y